Should Investors Chase Great Yields At AstraZeneca Plc (4.6%), Carillion Plc (6.8%) & Royal Mail Plc (4.7%)?

Are high dividends reason enough to bet on AstraZeneca Plc (LON: AZN), Royal Mail Plc (LON: RMG) and Carillion Plc (LON: CLLN)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As miners and oil producers begin slashing dividends to shore up balance sheets, should investors of all stripes consider 4%-plus dividends at AstraZeneca (LSE: AZN), Carillion (LSE: CLLN), and Royal Mail Group (LSE: RMG)?

AstraZeneca’s shares currently support a 4.6% yielding dividend covered 1.5 times by earnings. Cover will decrease through 2017 as revenue from blockbuster drugs Nexium and Crestor declines due to patent expirations, but this shouldn’t be a major worry. Management’s long-term goal of increasing revenue from $24bn annually in 2015 to $45bn by 2023 will require keeping institutional investors happy in the meantime. A dividend cut wouldn’t be the way to maintain their good will, suggesting dividends should be safe for years to come.

The company has gone on a substantial shopping spree to reach this revenue goal and spent $10bn in the past year alone. Alongside increased R&D spend, these efforts could bear significant fruit in the long term for investors. Shares aren’t a bargain at 15 times forward earnings, but an attractive yield and growth prospects shouldn’t be scoffed at.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Elusive growth

Construction and facilities management firm Carillion currently pays out a dividend yielding 6.9% covered 1.8 times by forecast earnings. With a dividend this high and shares trading at a mere eight times forward earnings, the shares certainly appear to be a bargain. However, the company is one of the most heavily shorted companies in the FTSE 350 due to concerns over mounting debt and lack of profit growth.

Over the past five years, revenue has fallen 17% and profits 15%. And although revenue finally returned to growth last year, earnings per share are forecast to be stubbornly flat in the near term. At the same time, debt has increased to three times earnings for a total of roughly £450m. Until management can return the company to reliable profit growth, I would avoid the shares as there remain safer dividends to be found.

Safety first?

Dividends at Royal Mail currently offer a 4.8% yield and are covered more than 1.5 times by forward earnings. The company is in the midst of a major restructuring effort as consumer habits shift dramatically. Letter volume, which still represents 60% of revenue, is falling steadily while package shipments increase precipitously. Unfortunately for Royal Mail, this growing market has attracted large international competitors, which will forestall massive profit growth.

Restructuring efforts should see Royal Mail’s estimated 2% to 3% operating margin gap with international competitors narrow. Therefore, even if revenue continues to increase by only 1% per annum, as it did in the past year, there’s room for profits to grow. Shares trade at a reasonable 12 times 2017 earnings and dividends have room to continue increasing incrementally. Royal Mail likely won’t offer runaway share price appreciation, but a safe dividend and steady growth do make it an interesting option for income investors.

British CEO gobbles up £238,000 of own stock

What company does he run?

And why is he so confident in its long-term potential?

This new report - ‘One Top Growth Stock from The Motley Fool’ - reveals the full details, both risks and opportunities. Some of which you may find frankly, unbelievable.

Though past performance does not guarantee future results, over the past 5 years, it’s seen consistent:

  • Double-digit revenue growth
  • Returns on capital almost 600% the UK average
  • Now, profits are exploding again - up 46% in 1 year!

It’s no wonder insiders are buying this stock hand over fist. Last year, they bought a total £492,000 of shares. And now might be the ideal moment to join them.

So please, don’t miss this report, ‘One Top Growth Stock from The Motley Fool’ Including both risks and opportunities.

Secure your FREE copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

2 reasons why this stock market crash isn’t a repeat of 2020

When the stock market crashed during the Covid-19 pandemic, the recovery was rapid and spectacular. Could the same thing happen…

Read more »

Investing Articles

Car-mageddon! The Aston Martin share price has tanked 30% in a month

Our writer looks at the performance of the Aston Martin share price over the past few weeks and considers whether…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing For Beginners

I was right about the UK stock impact from the tariff news. Here’s what I think happens next

Jon Smith explains why he warned about the impact of the tariffs on UK stocks and why more short-term pain…

Read more »

Investing Articles

Looking for penny shares? Here’s one I think looks like a terrific bargain to consider!

I think this penny share -- which has almost doubled in value over the last year -- is one of…

Read more »

Investing For Beginners

Why I’m staying away from the Barclays share price even with a 19% drop

Jon Smith explains why he's cautious right now about the Barclays share price, with the potential for lower revenues from…

Read more »

Investing Articles

2 FTSE 100 and FTSE 250 stocks to consider as stock markets plummet!

Looking for lifeboats as growth-crushing trade tariffs loom? Here are two (including a FTSE 100 gold stock) I think merit…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

£10,000 invested in Watches of Switzerland shares 1 year ago is now worth…

Watches of Switzerland shares have been decimated by Trump’s tariffs on Switzerland. Dr James Fox explores whether this is an…

Read more »